Comparison Overview

Innovative Control Inc

VS

Körber Pharma

Innovative Control Inc

2836 Corporate Pkwy, Algonquin, Illinois, 60102, US
Last Update: 2025-11-21

ICI specializes in automation services for projects ranging from a single loop control to Plant-Wide Systems of 65,000 Points. With the expertise to deliver solutions from developing a system architecture to installation supervision, ICI is the go to name for numerous industries around the world. Innovative Control, Inc. is a system integrator located in Algonquin, IL, northwest of Chicago. We specialize in Process Control and Automation, utilizing PC-based operator interfaces in conjunction with controllers (PAC/PLC), remote I/O, an advanced control software. As an integrated team, each individual contributes their own expertise to provide the best solutions for our customers. W offer a variety of additional services to help complete projects quickly and efficiently. Services include control panel design and assembly (including UL508A & UL698A), P&ID and functional system documentation, controller programming, SCADA/HMI development, data collection and reporting, and custom application development. Our Mission: To be the premiere resource for existing and future customer’s Process Control & Automation needs. Our Vision: We work closely with customers and their staff to communicate, educate, and share automation best practices and strategies, while providing quality solutions at the best price. Alliances ICI staff members are involved in various professional organizations. This group of select firms have developed standard business “Best Practices” that its members follow to assure that they provide clients with consistent quality engineering services. MESA International NFPA IEEE ISA UL508A UL698A (NITW, NNNY, NRBX) Need after hours support? Please call 1-844-520-7781, extension 73. Leave a message with your name and number, one of our skillfully trained staff will call within 30 minutes.

NAICS: None
NAICS Definition: Others
Employees: 22
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Körber Pharma

Anckelmannsplatz 1, Hamburg, 20537, DE
Last Update: 2025-11-21

We are the Business Area Pharma, part of the Körber Group – an international technology group with approx. 12,000 employees in more than 100 locations worldwide. We deliver the difference in pharma by integrating every aspect of the value chain into one seamless ecosystem. With a unique portfolio of 100% pharma-focused solutions, we optimize operations and enable our customers to navigate production challenges confidently. Our Körber Ecosystem approach represents a new standard for the industry, reducing complexity and risks and empowering you to grow. Our efficient and sustainable solutions connect production areas, machines and software. By seamlessly integrating all processes, systems and solutions, we enable our customers to master complexity, drive innovation and achieve a factory of excellence – with ‘Everything, Effortlessly, In one place.’ Ecosystem competence areas: IT & Digitalization: Körber drives digital excellence in pharma with software solutions such as PAS-X MES for end-to-end data tracking and Line Optimizer for eliminating production bottlenecks. Quality & Compliance: To ensure patient well-being, Körber helps customers maximize production potential while meeting regulatory requirements through SOP management, GMP consulting and training. Production: Körber's scalable solutions boost quality, efficiency and flexibility - from aseptic processing, handling and AI inspection to automated packaging, tailored to your challenges. Operational Excellence: Körber provides data-driven advice, digital transformation consulting, life cycle services and packaging innovation to achieve and maintain operational excellence. Supply Chain: Optimize your logistics with Körber’s automated guided vehicles and autonomous mobile robots, turning supply chain complexity into a competitive advantage and enhancing worker safety. Partner Network: Körber’s partner network strengthens the pharma supply chain, fostering end-to-end tech integration and sustainable growth.

NAICS: None
NAICS Definition: Others
Employees: 2,045
Subsidiaries: 8
12-month incidents
0
Known data breaches
1
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/innovative-control-inc.jpeg
Innovative Control Inc
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/koerber-pharma.jpeg
Körber Pharma
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Innovative Control Inc
100%
Compliance Rate
0/4 Standards Verified
Körber Pharma
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Industrial Automation Industry Average (This Year)

No incidents recorded for Innovative Control Inc in 2025.

Incidents vs Industrial Automation Industry Average (This Year)

No incidents recorded for Körber Pharma in 2025.

Incident History — Innovative Control Inc (X = Date, Y = Severity)

Innovative Control Inc cyber incidents detection timeline including parent company and subsidiaries

Incident History — Körber Pharma (X = Date, Y = Severity)

Körber Pharma cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/innovative-control-inc.jpeg
Innovative Control Inc
Incidents

No Incident

https://images.rankiteo.com/companyimages/koerber-pharma.jpeg
Körber Pharma
Incidents

Date Detected: 6/2023
Type:Breach
Attack Vector: Exploitation of MOVEit Transfer vulnerability CVE-2023-34362
Blog: Blog

FAQ

Innovative Control Inc company demonstrates a stronger AI Cybersecurity Score compared to Körber Pharma company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Körber Pharma company has historically faced a number of disclosed cyber incidents, whereas Innovative Control Inc company has not reported any.

In the current year, Körber Pharma company and Innovative Control Inc company have not reported any cyber incidents.

Neither Körber Pharma company nor Innovative Control Inc company has reported experiencing a ransomware attack publicly.

Körber Pharma company has disclosed at least one data breach, while Innovative Control Inc company has not reported such incidents publicly.

Neither Körber Pharma company nor Innovative Control Inc company has reported experiencing targeted cyberattacks publicly.

Neither Innovative Control Inc company nor Körber Pharma company has reported experiencing or disclosing vulnerabilities publicly.

Neither Innovative Control Inc nor Körber Pharma holds any compliance certifications.

Neither company holds any compliance certifications.

Körber Pharma company has more subsidiaries worldwide compared to Innovative Control Inc company.

Körber Pharma company employs more people globally than Innovative Control Inc company, reflecting its scale as a Industrial Automation.

Neither Innovative Control Inc nor Körber Pharma holds SOC 2 Type 1 certification.

Neither Innovative Control Inc nor Körber Pharma holds SOC 2 Type 2 certification.

Neither Innovative Control Inc nor Körber Pharma holds ISO 27001 certification.

Neither Innovative Control Inc nor Körber Pharma holds PCI DSS certification.

Neither Innovative Control Inc nor Körber Pharma holds HIPAA certification.

Neither Innovative Control Inc nor Körber Pharma holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Angular is a development platform for building mobile and desktop web applications using TypeScript/JavaScript and other languages. Prior to versions 19.2.16, 20.3.14, and 21.0.1, there is a XSRF token leakage via protocol-relative URLs in angular HTTP clients. The vulnerability is a Credential Leak by App Logic that leads to the unauthorized disclosure of the Cross-Site Request Forgery (XSRF) token to an attacker-controlled domain. Angular's HttpClient has a built-in XSRF protection mechanism that works by checking if a request URL starts with a protocol (http:// or https://) to determine if it is cross-origin. If the URL starts with protocol-relative URL (//), it is incorrectly treated as a same-origin request, and the XSRF token is automatically added to the X-XSRF-TOKEN header. This issue has been patched in versions 19.2.16, 20.3.14, and 21.0.1. A workaround for this issue involves avoiding using protocol-relative URLs (URLs starting with //) in HttpClient requests. All backend communication URLs should be hardcoded as relative paths (starting with a single /) or fully qualified, trusted absolute URLs.

Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Uncontrolled Recursion vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft deep ASN.1 structures that trigger unbounded recursive parsing. This leads to a Denial-of-Service (DoS) via stack exhaustion when parsing untrusted DER inputs. This issue has been patched in version 1.3.2.

Risk Information
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Forge (also called `node-forge`) is a native implementation of Transport Layer Security in JavaScript. An Integer Overflow vulnerability in node-forge versions 1.3.1 and below enables remote, unauthenticated attackers to craft ASN.1 structures containing OIDs with oversized arcs. These arcs may be decoded as smaller, trusted OIDs due to 32-bit bitwise truncation, enabling the bypass of downstream OID-based security decisions. This issue has been patched in version 1.3.2.

Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. Prior to versions 7.0.13 and 8.0.2, working with large buffers in Lua scripts can lead to a stack overflow. Users of Lua rules and output scripts may be affected when working with large buffers. This includes a rule passing a large buffer to a Lua script. This issue has been patched in versions 7.0.13 and 8.0.2. A workaround for this issue involves disabling Lua rules and output scripts, or making sure limits, such as stream.depth.reassembly and HTTP response body limits (response-body-limit), are set to less than half the stack size.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Description

Suricata is a network IDS, IPS and NSM engine developed by the OISF (Open Information Security Foundation) and the Suricata community. In versions from 8.0.0 to before 8.0.2, a NULL dereference can occur when the entropy keyword is used in conjunction with base64_data. This issue has been patched in version 8.0.2. A workaround involves disabling rules that use entropy in conjunction with base64_data.

Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H